SANUWAVE Health, Inc.
SNWV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11,451 | $10,164 | $9,342 | $10,326 |
| % Growth | 12.7% | 8.8% | -9.5% | – |
| Cost of Goods Sold | $2,748 | $2,206 | $1,958 | $2,285 |
| Gross Profit | $8,703 | $7,958 | $7,384 | $8,041 |
| % Margin | 76% | 78.3% | 79% | 77.9% |
| R&D Expenses | $345 | $194 | $208 | $154 |
| G&A Expenses | $4,810 | $4,039 | $4,467 | $3,289 |
| SG&A Expenses | $6,891 | $5,713 | $5,998 | $5,144 |
| Sales & Mktg Exp. | $2,081 | $1,674 | $1,531 | $1,855 |
| Other Operating Expenses | $0 | $174 | $192 | $221 |
| Operating Expenses | $7,236 | $6,081 | $6,398 | $5,519 |
| Operating Income | $1,467 | $1,877 | $986 | $2,522 |
| % Margin | 12.8% | 18.5% | 10.6% | 24.4% |
| Other Income/Exp. Net | $8,858 | -$822 | -$6,662 | -$15,243 |
| Pre-Tax Income | $10,325 | $1,055 | -$5,676 | -$12,721 |
| Tax Expense | $0 | $0 | $0 | $27 |
| Net Income | $10,325 | $1,055 | -$5,676 | -$12,748 |
| % Margin | 90.2% | 10.4% | -60.8% | -123.5% |
| EPS | 1.205 | 0.008 | -0.66 | -3.33 |
| % Growth | 15,755.3% | 101.2% | 80.2% | – |
| EPS Diluted | 1.13 | 0.007 | -0.66 | -3.33 |
| Weighted Avg Shares Out | 8,571 | 8,562 | 8,548 | 3,824 |
| Weighted Avg Shares Out Dil | 9,141 | 9,168 | 8,548 | 3,824 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,722 | $1,874 | $1,852 | $2,633 |
| Depreciation & Amortization | $329 | $299 | $274 | $409 |
| EBITDA | $12,376 | $3,228 | -$3,550 | -$9,679 |
| % Margin | 108.1% | 31.8% | -38% | -93.7% |